文献速递生殖医学

孕酮与LH峰监测在自然周期冻胚移植中的活产率比较

Progesterone-based ovulation timing versus LH surge monitoring in true natural cycle frozen embryo transfer: impact on live birth rates in a prospective cohort study.
PubMed 文献 · Hum Reprod · 2026-01-01

该前瞻性队列研究纳入490个真自然周期冻胚移植周期,比较基于孕酮与基于LH峰的排卵时机安排移植对活产率的影响。孕酮组活产率56.6%,LH组52.0%,未调整RR 1.09(95%CI 0.93-1.28);调整混杂后仍无独立关联(调整RR 1.09,95%CI 0.93-1.30;P=0.264)。

要点

  • 真自然周期冻胚移植中,基于孕酮安排移植的活产率与基于LH峰安排相当。
  • 调整潜在混杂因素后,排卵时机策略与活产无独立关联(调整RR 1.09,P=0.264)。
  • 孕酮阈值来自单中心检测环境,推广至其他平台需谨慎。

核心结论

  • 在真自然周期冻胚移植中,基于孕酮的移植时机与基于LH峰的时机相比,活产率相当,调整后无独立关联证据。

研究设计与样本

  • 前瞻性队列研究,纳入2022至2025年单中心490个真自然周期冻胚移植周期,孕酮组286例,LH峰组204例。

主要发现

  • 孕酮组活产162/286(56.6%),LH组106/204(52.0%),未调整RR 1.09(95%CI 0.93-1.28)。
  • 调整后RR 1.09(95%CI 0.93-1.30;P=0.264),调整绝对风险差+4.9%(95%CI -3.8%至+13.6%)。
  • 临床妊娠、hCG阳性及流产率两组相当。
  • 探索性分析:排卵前1天卵泡大小与移植日孕酮正相关(Spearman r=0.36,P<0.001)。
  • 探索性分析:移植日孕酮与排卵前1天雌二醇正相关(Spearman r=0.29,P<0.001)。

临床怎么用

  • 孕酮-based时机可作为真自然周期冻胚移植中LH峰监测的可行替代方案。
  • 应用孕酮阈值时需考虑本中心检测平台,跨中心推广前需验证。

局限性

  • 观察性设计,尽管统计调整仍可能存在残余混杂。
  • 时机策略非随机,反映机构方案演变。
  • 孕酮阈值源自单中心检测环境,可能限制外推至其他临床设置和实验室平台。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does progesterone-based embryo transfer timing achieve live birth rates comparable to LH-surge-based timing in true natural cycle frozen embryo transfer (NC-FET)? SUMMARY ANSWER: Progesterone-based embryo transfer timing was associated with live birth rates comparable to those achieved with LH surge-based timing in true NC-FET, with no evidence of an independent association between ovulation timing strategy and live birth after adjustment for potential confounders. WHAT IS KNOWN ALREADY: In true NC-FET, embryo transfer timing is commonly scheduled according to the LH surge. However, identification of the LH surge may be challenging. Serum progesterone rise may reflect ovulation timing, yet its use as an alternative approach for scheduling embryo transfer in NC-FET cycles remains insufficiently investigated. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 490 true NC-FET cycles performed at a single tertiary IVF center between 2022 and 2025. Cycles were analyzed according to the ovulation timing strategy used for embryo transfer scheduling: progesterone-based timing (n = 286) or LH surge-based timing (n = 204). PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovulation was monitored using serial ultrasound and serum hormone measurements. Embryo transfer timing was scheduled according to either detection of the LH surge or the rise in serum progesterone concentrations. The primary outcome was live birth. Adjusted relative risks were estimated using modified Poisson regression with robust standard errors, adjusting for infertility duration and etiology, endometrial thickness at transfer, embryo quality, and number of embryos transferred. Adjusted absolute risk differences were calculated using marginal standardization. An exploratory threshold-based assessment was performed on the risk-difference scale. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth occurred in 162 of 286 progesterone-timed cycles (56.6%) and 106 of 204 LH-timed cycles (52.0%) (unadjusted RR 1.09, 95% CI 0.93-1.28). After adjustment, ovulation timing strategy showed no evidence of an independent association with live birth (adjusted RR 1.09, 95% CI 0.93-1.30; P = 0.264). The adjusted absolute risk difference was +4.9% (95% CI -3.8% to +13.6%). Clinical pregnancy, hCG positivity, and miscarriage rates were also comparable between groups. In exploratory analyses, follicle size measured 1 day before ovulation was positively correlated with progesterone levels on the embryo transfer day (Spearman r = 0.36, P < 0.001), and embryo-transfer-day progesterone levels were positively correlated with estradiol levels measured 1 day before ovulation (Spearman r = 0.29, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The observational design may introduce residual confounding despite statistical adjustment. The timing strategy was not randomized and reflected an evolving institutional protocol. In addition, the progesterone thresholds were derived and applied within a single-center assay environment, which may limit generalizability to other clinical settings and laboratory platforms. WIDER IMPLICATIONS OF THE FINDINGS: Progesterone-based timing may represent a feasible alternative to LH-based scheduling in true NC-FET, although confirmation in adequately powered multicenter studies is required. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Aydin T, Koroglu N, Kahraman E, et al. Progesterone-based ovulation timing versus LH surge monitoring in true natural cycle frozen embryo transfer: impact on live birth rates in a prospective cohort study. Hum Reprod. 2026. PMID: 42449543. doi:10.1093/humrep/deag109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。